As of 2026-10-09, the Relative Valuation of Athira Pharma Inc (ATHA) is (105.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.75 USD, the upside of Athira Pharma Inc based on Relative Valuation is -1660.3%.
The range of the Relative Valuation is (76.79) - (119.30) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 8.0x - 12.5x | 11.0x |
| Fair Price | (76.79) - (119.30) | (105.32) |
| Upside | -1237.6% - -1867.4% | -1660.3% |
| Date | P/E |